medline.ch Dermatologie Tumoren

	Anlotinib as Third-Line or Later Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Real-World Efficacy and Safety Outcomes. Drug Des Devel Ther Li Y, Li S, Li Y, Pan Z. PMID: 42318078 [PubMed - indexed for MEDLINE]
	The design of a small Bayesian hybrid-controlled trial utilizing time-to-event data from six published sources that used best alternative care to treat liver-predominant metastasis from primary ocular melanoma. Contemp Clin Trials Commun Zahrieh D, Wang X, Markovic SN, Suman VJ. PMID: 42317800 [PubMed]
	Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response. Front Immunol Wang C, Geng X, Cheng X, Ren R, Jin L, Sheng Z, Li S, Zang M, Zhang Y. PMID: 42317368 [PubMed - indexed for MEDLINE]
	Stratified lymph node yield thresholds after neoadjuvant immunochemotherapy: a surgical benchmark for survival in oral squamous cell carcinoma. Front Immunol Yuan S, Hu Y, Hou Y, Wei Y, Fang Q, Liu F. PMID: 42317358 [PubMed - indexed for MEDLINE]
	Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation-Pilot Study. Clin Transl Sci Losol P, O'Driscoll D, Pulido AV, von Witzleben A, Boukas K, Sommerlad M, Ottensmeier C, Ardern-Jones MR. PMID: 42316430 [PubMed - indexed for MEDLINE]
	Cellular immunotherapy in melanoma: the next frontier in cancer treatment. J Exp Clin Cancer Res Wien AL, Stamtsis-Datsi A. PMID: 42316257 [PubMed - indexed for MEDLINE]
	Genetic predisposition to malignancy confers different outcomes in malignant cutaneous melanoma: A retrospective cohort matched study using TriNetX. J Am Acad Dermatol Nassief G, Kaelber D, Nowacki AS, Arbesman J. PMID: 42314938 [PubMed - as supplied by publisher]
	A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217). Dig Endosc Tanaka M, Ono H, Takizawa K, Iwamoto S, Sano Y, Abe S, Kadota T, Wada T, Ishiyama A, Nakanishi H, Nagata S, Fukuda H, Muto M, Yano T, Gastrointestinal Endoscopy Study Group of the Japan Clinical Oncology Group. PMID: 42313516 [PubMed - indexed for MEDLINE]
	[Therapy of melanoma : Current standards and future perspectives]. Pathologie (Heidelb) Hariri I, Hassel JC. PMID: 42313150 [PubMed - as supplied by publisher]
	Original Article \| Epstein-Barr Virus Seroprevalence and Associated Risk Factors in Head and Neck Squamous Cell Carcinoma: A Cross-Sectional Study from Aden, Yemen. Gulf J Oncolog Hamid GA, Atef AM. PMID: 42312826 [PubMed - indexed for MEDLINE]
	Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Melanoma: A Systematic Review of Phase One Clinical Trials. Technol Cancer Res Treat Shet P, Ghosh P, Varshney K, Sawdagar S. PMID: 42310990 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma-Results from the Prospective NeoACTIVATE Arm C (NCT03554083) Substudy. Ann Surg Oncol Hieken TJ, Flotte TJ, Zahrieh D, Johnson JE, Piltin MA, Tasche KK, Nelson GD, Strand CA, Jakub JW, Pirgousis P, Khariwala SS, Tuttle T, Block MS. PMID: 42310271 [PubMed - as supplied by publisher]
	Diagnostic Utility of PRAME Immunohistochemistry for Distinguishing Acral Melanoma From Acral Melanocytic Nevi. J Cutan Pathol Phatcharamaneepakorn K, Sitthinamsuwan P, Pattanaprichakul P, Chairatchaneeboon M, Yodrabum N. PMID: 42309778 [PubMed - as supplied by publisher]
	Occupational solar UV-exposure and risk of cutaneous melanoma among Danish workers: A nationwide cohort study. Eur J Cancer Kristensen I, Schmidt SAJ, Gorny AW, Iversen IB, Fenger-Grøn M, Würtz ET, Turner MC, Grandahl K, Kolstad HA, Stokholm ZA. PMID: 42308861 [PubMed - as supplied by publisher]
	Comment on 'Nail matrix melanoma in adolescents and young adults: a retrospective dermoscopic study': Do observations justify revision of diagnostic criteria? Clin Exp Dermatol Zhang Q, Meng Z, Zou Y. PMID: 42308541 [PubMed - as supplied by publisher]
	Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS). JCO Glob Oncol Kapoor A, Gupta A, Sansar B, Mishra BK, Singh A, Upadhyay A, Pal A, Kumari R, Sisodia N, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Choubey A, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, Shukla S, Singh SN, Suresh A, Dey S, Vinayak KR, Lakshman P, Gupta L, Gavel P, Bajpai V, Bandekar B, Banavali SD, Patil VM, Noronha V, Prabhash K. PMID: 42308452 [PubMed - indexed for MEDLINE]
	Oral Melanoma: A South American Collaborative Series of 21 Cases. Head Neck Pathol de Arruda JAA, Villarroel-Dorrego M, Peña-Vega CP, Rodríguez-Mora JP, Gilligan G, Panico R, Gimenez J, Flück V, Castrillo Á, Scalise G, Leguina L, Monteiro MDS, Sampaio GC, Drumond VZ, Tenório JR, de Andrade BAB. PMID: 42307794 [PubMed - indexed for MEDLINE]
	Repurposing statins for the management of head and neck squamous cell carcinoma: A systematic review of preclinical and clinical evidence. Med Oncol Famta P, Vambhurkar G, Pandey G, Wagh S, Sharma A, Pandia C, Samadder B, Srivastava S. PMID: 42307682 [PubMed - indexed for MEDLINE]
	"Osteoid" Syringoma: A Report of Two Cases of Cutaneous Mixed Tumor With Extensive Ossification and Review of the Literature. Am J Dermatopathol Maverakis Ramirez N, Jaeger ZJ, Hinds BR. PMID: 42307596 [PubMed - indexed for MEDLINE]
	Ultraviolet radiation as a double-edged regulator of melanocyte function in vitiligo therapy and melanoma carcinogenesis. Front Med (Lausanne) Fan HH, Chen YY, Geng Y, Yang YF, Xu H, Xiong YY, Zheng YW, Li YM. PMID: 42305972 [PubMed]

Artikel 1 - 20 / 143329

Seite 1 von 7167

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung